GNK's sales drop 2.1% & FCF margin falls 55.6 pts. EPAM & SSB show strong growth & solid P/E & P/B ratios.

NOVT's 33.3x P/E signals risk despite revenue growth. TRUP's flat book value & negative ROE raise concerns. THR's 12.4% revenue growth & 46.1% EPS growth at 22.3x P/E looks promising.

CRWD's ARR hits $5.2B, up 24%, but it's still not profitable. Low debt, high growth.

ORCL jumps 2.7% on geopolitical relief, but its 53% discount to 52-week high hints at volatility.

RDNT insider sells 15K shares amid 12% 2026 drop, but still holds 1.2M+ shares. Focus on growth.

JEF +4.7%, SEZL +10.2% on de-escalation news. SEZL still 60% below high.

IBRX jumps 11% on Macau approval; 275% YTD gains but high risk remains.